[Conservative treatment of arteriosclerosis obliterans].
The conservative therapy of the arteriosclerotic obstructive disease demands a complex approach. The basis therapy, the symptomatic treatment of the haemodynamics of the extremity with ill vessels, the pathogenetically oriented therapy as well as the treatment of other localisations of the arteriosclerosis should be used combined. At stage III and IV additional measures, such as combat against pain, therapy with antibiotics and local treatment of tissue lesions are necessary. The results of the therapy should be critically tested not only on the basis of the clinical picture, but also on the basis of the course of the vascular processes.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001162:Arteriosclerosis Obliterans / Q000628:therapy*; D001809:Blood Viscosity / Q000187:drug effects; D005734:Gangrene / Q000188:drug therapy; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D012306:Risk; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D009125:Muscle Relaxants, Central; D014665:Vasodilator Agents
Konservative Behandlung der Arteriosclerosis obliterans.